IMMUNOTHERAPY BRIDGE
November 30th - December 1th, 2022

FACULTY

Paolo A. Ascierto

Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

 Antonio Avallone

MD, Unit of Abdominal Medical Oncology, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Robert A. Beckman

Professor of Oncology and Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Innovation Center of Biomedical Informatics, Georgetown University Medical Center, Washington, DC, US

Carlo Bifulco

Medical Director of Oncological Molecular Pathology and Pathology Informatics, Providence Oregon Regional Laboratory, Director of Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US

Christian Blank

Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Sergio Bracarda

Director, Department of Oncology and Medical & Translational Oncology Unit, Santa Maria Hospital, Terni, Italy

Renier Brentjens

Deputy Director & Chair, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Joshua Brody

Director, Lymphoma Immunotherapy Program, Hess Center for Science and Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, US

Alfredo Budillon

Scientific Director, National Cancer Institute“Fondazione G. Pascale”, Naples, Italy

Luigi Buonaguro

Director, Innovative Immunological Models Unit, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Elizabeth M. Burton

Director, Research Planning & Development, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Lisa H. Butterfield

Adjunct Professor, Microbiology and Immunology, University of California San Francisco; Vice President, PICI Research Center/ PICI Research & Development, San Francisco, CA, US

Tina Cascone

Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

 

Bruno Daniele

Director, Oncology Unit, “Ospedale del Mare” Hospital, Naples, Italy

Leisha A. Emens

Professor of Medicine, Director of Translational Immunotherapy for the Women’s Cancer Research Center, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, UPMC Hillman Cancer Center/Magee Women’s Hospital, Pittsburgh, PA, US

Robert L. Ferris

Director, UPMC Hillman Cancer Center, Professor of Oncology, Associate Vice Chancellor for Cancer Research, Co-Director, Tumor Microenvironment Center, Professor of Otolaryngology, of Immunology, and of Radiation Oncology, University Pittsburgh School of Medicine, PA, US

Silvia Chiara Formenti

Chairman of the Department of Radiation Oncology, Weill Cornell Medicine; Associate Director of the Meyer Cancer Center, Radiation Oncologist in Chief, New York-Presbyterian Hospital, New York, NY, US

Bernard A. Fox

Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US

Neil D. Gross

Professor and Director of Clinical Research, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, US

John B. Haanen

Leader Research Theme Immunotherapy, Netherlands Cancer Institute; Professor of Translational Immunotherapy of Cancer, Leiden University Medical Center (LUMC), Amsterdam, The Netherlands

Omid Hamid

Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US

Douglas B. Johnson

Associate Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, US

Samir N. Khleif

Director of the Center for Immunology and Immunotherapy, Director of The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington,DC, US

Tomas Kirchhoff

Associate Professor, Department of Population Health, Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US

Christopher A. Klebanoff

Head, Breast Immunotherapy Section, Memorial Sloan Kettering Cancer Center, New York, NY, US

Gregory B. Lesinski

Professor, Vice Chair for Basic Research, Department of Hematology & Medical Oncology, Associate Director for Basic Research, Co-Director, Translational GI Malignancy Program, Winship Cancer Institute of Emory University, Atlanta, GA, US

Marcela V. Maus

Associate Professor of Medicine, Harvard Medical School; Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, Boston, MA, US

Anne Monette

Lady Davis Institute for Medical Research; Sir Mortimer B. Davis – Jewish General Hospital, Montreal, Quebec, Canada

Bart Neyns

Head of Department Medical Oncology, Universitair Ziekenhuis (UZ) Brussel; Clinical Professor at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium

Kunle Odunsi

Professor of Medicine, Director of Comprehensive Cancer Research Center, Dean for Oncology, Biological Sciences Division, The University of Chicago Medical Center, Chicago, IL, US

Chrystal M. Paulos

Associate Professor, Department of Surgery / Microbiology & Immunology, Director of Translational Research, Cutaneous Malignancies, Winship Cancer Institute at Emory University Atlanta, GA, US

Igor Puzanov

Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Katy Rezvani

Sally Cooper Murray Chair in Cancer Research, Professor of Medicine, Chief, Section of Cellular Therapy, Director, Cell Engineering GMP Lab, Executive Director, Adoptive Cell therapy Platform, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Brahm Segal

Chair, Department of Internal Medicine, Chief, Division of Infectious Diseases, Professor of Oncology Member, Department of Immunology, Roswell Park Comprehensive Cancer Center; Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, US

 

Ryan J. Sullivan

Associate Professor of Medicine, Harvard Medical School; Associate Professor of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, US